{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:14:51Z","timestamp":1791231291823,"version":"4.1.0"},"reference-count":105,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Plasminogen activator inhibitor type 1 (PAI-1) is a main inhibitor of fibrinolysis. The PAI-1 gene (SERPINE1) harbors genetic variants with the potential of modifying plasma levels of PAI-1. A delicate balance exists between the coagulation and fibrinolytic system, and changes in PAI-1 have been suggested to compromise establishment of a successful pregnancy. Therefore, this systematic review investigated the association between genetic variants and\/or plasma levels of PAI-1 and placenta-mediated pregnancy complications. An extensive literature search was conducted in PubMed, Embase, and Web of Science on the 29th of April 2021. All studies underwent quality rating according to The Study Quality Assessment Tools checklist provided by National Heart, Lung and Blood Institute. A total of 71 studies were included, among which 60 studies investigated PAI-1 genotypes and 11 studies measured PAI-1 plasma levels. In 32 out of 59 studies, no association was found between the PAI-1 4G\/5G polymorphism (rs1799768) and placenta-mediated pregnancy complications, which was stated as no significant difference in the genotype distribution comparing women with and without placenta-mediated pregnancy complications or no significantly increased odds of placenta-mediated pregnancy complications carrying the 4G\/4G or 4G\/5G genotype. Eight out of 11 studies reported significantly higher PAI-1 plasma levels in preeclamptic women than in women without preeclampsia. In conclusion, no clear evidence indicates that PAI-1 polymorphisms are associated with placenta-mediated pregnancy complications, and the possible association between high PAI-1 plasma levels and preeclampsia needs further investigations. Thus, investigation of PAI-1 genotypes and PAI-1 plasma levels does not currently seem to have a place in daily clinical practice managing placenta-mediated pregnancy complications.<\/jats:p>","DOI":"10.1055\/s-0041-1742082","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T23:48:20Z","timestamp":1642031300000},"page":"607-624","source":"Crossref","is-referenced-by-count":19,"title":["The Role of Plasminogen Activator Inhibitor Type 1 (PAI-1) in Placenta-Mediated Pregnancy Complications: A Systematic Review"],"prefix":"10.1055","volume":"48","author":[{"given":"Ida","family":"Agersnap","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Nissen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department for Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Mette","family":"Hvas","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department for Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"issue":"08","key":"ref1","doi-asserted-by":"crossref","first-page":"E1651","DOI":"10.3390\/ijms18081651","article-title":"Role of plasminogen activator inhibitor type 1 in pathologies of female reproductive diseases","volume":"18","author":"Y Ye","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/j.1460-2075.1986.tb04532.x","article-title":"Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family","volume":"5","author":"H Pannekoek","year":"1986","journal-title":"EMBO J"},{"issue":"24","key":"ref3","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199212103272406","article-title":"Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation","volume":"327","author":"W P Fay","year":"1992","journal-title":"N Engl J Med"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0030-1270334","article-title":"Plasminogen activator inhibitor-1 gene polymorphisms in pre-eclampsia","volume":"37","author":"A V D'Elia","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"19","key":"ref5","doi-asserted-by":"crossref","first-page":"9129","DOI":"10.1016\/S0021-9258(19)76517-X","article-title":"Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences","volume":"263","author":"P J Bosma","year":"1988","journal-title":"J Biol Chem"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/ATVBAHA.107.149468","article-title":"Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study","volume":"27","author":"P E Morange","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"ref7","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)82047-6","article-title":"The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells","volume":"268","author":"S J Dawson","year":"1993","journal-title":"J Biol Chem"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","article-title":"Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction","volume":"92","author":"P Eriksson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1055\/s-0038-1649833","article-title":"The 4G\/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde","volume":"74","author":"S Ye","year":"1995","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2003-38897","article-title":"Hemostasis during normal pregnancy and puerperium","volume":"29","author":"M Hellgren","year":"2003","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-2115(97)02734-6","article-title":"Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis","volume":"73","author":"F Cerneca","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood.V69.2.460.460","article-title":"Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors","volume":"69","author":"E K Kruithof","year":"1987","journal-title":"Blood"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1521-6934(03)00006-3","article-title":"Inherited thrombophilia and poor pregnancy outcome","volume":"17","author":"B Brenner","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1055\/s-2007-985756","article-title":"Do thrombophilias cause placenta-mediated pregnancy complications?","volume":"33","author":"M A Rodger","year":"2007","journal-title":"Semin Thromb Hemost"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/14767050701670191","article-title":"The role of second trimester ultrasound in the diagnosis of placental hypoechoic lesions leading to poor pregnancy outcome","volume":"20","author":"A Kofinas","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.placenta.2010.10.006","article-title":"Pathologic basis of echogenic cystic lesions in the human placenta: role of ultrasound-guided wire localization","volume":"31","author":"L K Proctor","year":"2010","journal-title":"Placenta"},{"issue":"07","key":"ref17","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/j.1538-7836.2012.04773.x","article-title":"Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort","volume":"10","author":"J A Lykke","year":"2012","journal-title":"J Thromb Haemost"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"E Rey","year":"2003","journal-title":"Lancet"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/jth.12509","article-title":"Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study","volume":"12","author":"M A Rodger","year":"2014","journal-title":"J Thromb Haemost"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"D Moher","year":"2009","journal-title":"BMJ"},{"issue":"09","key":"ref22","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/j.1538-7836.2004.00861.x","article-title":"Preeclampsia and its interaction with common variants in thrombophilia genes","volume":"2","author":"M P De Maat","year":"2004","journal-title":"J Thromb Haemost"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jri.2014.02.007","article-title":"Prevalence of coagulation factor XIII and plasminogen activator inhibitor-1 gene polymorphisms among Egyptian women suffering from unexplained primary recurrent miscarriage","volume":"103","author":"I R Elmahgoub","year":"2014","journal-title":"J Reprod Immunol"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1538-7836.2005.01226.x","article-title":"The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G\/5G genotype are associated with early onset of severe preeclampsia","volume":"3","author":"A Gerhardt","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref25","first-page":"44","article-title":"Genetic hypofibrinolysis in complicated pregnancies","volume":"97","author":"C J Glueck","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.ede.0000158199.64871.b9","article-title":"Thrombophilic polymorphisms and intrauterine growth restriction","volume":"16","author":"C Infante-Rivard","year":"2005","journal-title":"Epidemiology"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1160\/TH13-03-0242","article-title":"Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women","volume":"110","author":"Y J Jeon","year":"2013","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1160\/TH04-08-0519","article-title":"Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage. Results of a multicentre case-control study","volume":"93","author":"M Krause","year":"2005","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/aji.12116","article-title":"Plasminogen activator inhibitor 1 4G\/5G and -844G\/A variants in idiopathic recurrent pregnancy loss","volume":"70","author":"K Magdoud","year":"2013","journal-title":"Am J Reprod Immunol"},{"issue":"05","key":"ref30","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00404-013-2877-x","article-title":"Polymorphisms in MTHFR, MTHFD, and PAI-1 and recurrent miscarriage among North Indian women","volume":"288","author":"F Parveen","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"07","key":"ref31","first-page":"249","article-title":"Inherited thrombophilia and pregnancy loss. Study of an Argentinian cohort","volume":"152","author":"S Per\u00e9s Wingeyer","year":"2019","journal-title":"Med Clin (Barc)"},{"issue":"05","key":"ref32","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1538-7836.2012.04700.x","article-title":"The PAI-1 4G\/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women","volume":"10","author":"J M Said","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"468.e1","DOI":"10.1016\/j.ajog.2016.04.026","article-title":"Factor V Leiden, prothrombin G20210A, and methylene tetrahydrofolate reductase mutations and stillbirth: the Stillbirth Collaborative Research Network","volume":"215","author":"R M Silver","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.preghy.2018.01.009","article-title":"Serum protein marker panel for predicting preeclampsia","volume":"14","author":"L Cui","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/10641955.2016.1211676","article-title":"Fibrinolysis parameters in Sudanese women with severe preeclampsia","volume":"35","author":"H O Elzein","year":"2016","journal-title":"Hypertens Pregnancy"},{"issue":"03","key":"ref36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1034\/j.1600-0412.1999.780304.x","article-title":"Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia","volume":"78","author":"R Schjetlein","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/14767058.2010.511331","article-title":"Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor XIII genes in patients with recurrent spontaneous abortion","volume":"24","author":"M Aarabi","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"02","key":"ref38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000273067","article-title":"Polymorphisms in NOS3, ACE and PAI-1 genes and risk of spontaneous recurrent miscarriage in the Gaza Strip","volume":"19","author":"R J Al Sallout","year":"2010","journal-title":"Med Princ Pract"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.12891\/ceog3556.2017","article-title":"Inherited thrombophilia and thromboprophylaxis: a retrospective analysis of pregnancy outcomes in 106 patients","volume":"44","author":"H Alptekin","year":"2017","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"07","key":"ref40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5603\/GP.2016.0034","article-title":"Correlation between factor VII and PAI-1 genetic variants and recurrent miscarriage","volume":"87","author":"M Barlik","year":"2016","journal-title":"Ginekol Pol"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.17772\/gp\/2073","article-title":"The contribution of Hind III C>G PAI-1 gene polymorphism in etiology of recurrent miscarriages","volume":"86","author":"M Barlik","year":"2015","journal-title":"Ginekol Pol"},{"issue":"21","key":"ref42","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1182\/blood.V122.21.4795.4795","article-title":"Polymorphisms in thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor type 1 in women with primary recurrent pregnancy loss","volume":"122","author":"J F Bertinato","year":"2013","journal-title":"Blood"},{"issue":"02","key":"ref43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000478084","article-title":"Association of plasminogen activator inhibitor-1 gene polymorphisms and methylene tetrahydrofolate reductase polymorphisms with spontaneous miscarriages","volume":"138","author":"P Bubalo","year":"2017","journal-title":"Acta Haematol"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/humrep\/deg474","article-title":"Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages","volume":"18","author":"T Buchholz","year":"2003","journal-title":"Hum Reprod"},{"issue":"02","key":"ref45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bcmd.2006.07.005","article-title":"Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population","volume":"37","author":"C A Dalm\u00e1z","year":"2006","journal-title":"Blood Cells Mol Dis"},{"issue":"02","key":"ref46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/14647273.2016.1255785","article-title":"Genetics of suspected thrombophilia in Serbian females with infertility, including three cases, homozygous for FII 20210A or FV 1691A mutations","volume":"20","author":"J Djurovic","year":"2017","journal-title":"Hum Fertil (Camb)"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000072326","article-title":"Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia","volume":"56","author":"D Fabbro","year":"2003","journal-title":"Gynecol Obstet Invest"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/aji.12516","article-title":"Plasminogen activator inhibitor-1 4G\/5G polymorphism is associated with reproductive failure: metabolic, hormonal, and immune profiles","volume":"76","author":"M D Salazar Garcia","year":"2016","journal-title":"Am J Reprod Immunol"},{"issue":"03","key":"ref49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/109065703322537313","article-title":"Plasminogen activator inhibitor-1 polymorphism in women with pre-eclampsia","volume":"7","author":"T H\u00e4kli","year":"2003","journal-title":"Genet Test"},{"issue":"05","key":"ref50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/aji.12002","article-title":"Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in Iranian women with polycystic ovary syndrome","volume":"68","author":"F Idali","year":"2012","journal-title":"Am J Reprod Immunol"},{"issue":"02","key":"ref51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0897.2010.00974.x","article-title":"Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss","volume":"66","author":"M Jeddi-Tehrani","year":"2011","journal-title":"Am J Reprod Immunol"},{"issue":"02","key":"ref52","first-page":"199","article-title":"Combined presence of coagulation factor XIII V34L and plasminogen activator inhibitor 1 4G\/5G gene polymorphisms significantly contribute to recurrent pregnancy loss in Serbian population","volume":"39","author":"I Joksic","year":"2020","journal-title":"J Med Biochem"},{"issue":"02","key":"ref53","first-page":"158","article-title":"The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G\/5G polymorphisms with recurrent pregnancy loss in Bosnian women","volume":"15","author":"A Jusi\u0107","year":"2018","journal-title":"Med Glas (Zenica)"},{"issue":"07","key":"ref54","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2310\/JIM.0b013e31822c5bdf","article-title":"Do serum angiopoietin-1, angiopoietin-2, and their receptor Tie-2 and 4G\/5G variant of PAI-1 gene have a role in the pathogenesis of preeclampsia?","volume":"59","author":"M Kamal","year":"2011","journal-title":"J Investig Med"},{"issue":"01","key":"ref55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10815-013-0125-8","article-title":"Association between plasminogen activator inhibitor 1 gene mutation and different subgroups of recurrent miscarriage and implantation failure","volume":"31","author":"F Khosravi","year":"2014","journal-title":"J Assist Reprod Genet"},{"issue":"06","key":"ref56","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/aji.12302","article-title":"The PAI-1 4G\/5G and ACE I\/D polymorphisms and risk of recurrent pregnancy loss: a case-control study","volume":"72","author":"J J Kim","year":"2014","journal-title":"Am J Reprod Immunol"},{"issue":"04","key":"ref57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.17772\/gp\/62203","article-title":"Coexistence of ACE (I\/D) and PAI-1 (4G\/5G) gene variants in recurrent miscarriage in Polish population","volume":"87","author":"G Kurzawi\u0144ska","year":"2016","journal-title":"Ginekol Pol"},{"issue":"04","key":"ref58","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/1076029613520465","article-title":"Thrombophilic mutations and polymorphisms, alone or in combination, and recurrent spontaneous abortion","volume":"21","author":"F L Lino","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"issue":"04","key":"ref59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/gtmb.2011.0191","article-title":"Recurrent pregnancy loss and its relation to combined parental thrombophilic gene mutations","volume":"16","author":"O Ozdemir","year":"2012","journal-title":"Genet Test Mol Biomarkers"},{"issue":"03","key":"ref60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bcmd.2015.06.008","article-title":"Inherited and acquired thrombophilia in Indian women experiencing unexplained recurrent pregnancy loss","volume":"55","author":"R Patil","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"04","key":"ref61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1034\/j.1600-0412.2003.00085.x","article-title":"Plasminogen activator inhibitor type 1 (PAI1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in Black South Africans with pre-eclampsia","volume":"82","author":"R J Pegoraro","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"03","key":"ref62","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/01443615.2013.836476","article-title":"Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage","volume":"34","author":"A Pietropolli","year":"2014","journal-title":"J Obstet Gynaecol"},{"issue":"02","key":"ref63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03346557","article-title":"Angiotensin-converting enzyme D\/I and plasminogen activator inhibitor-1 4G\/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome","volume":"33","author":"L Sun","year":"2010","journal-title":"J Endocrinol Invest"},{"issue":"02","key":"ref64","first-page":"89","article-title":"Combination of thrombophilic gene polymorphisms as a cause of increased the risk of recurrent pregnancy loss","volume":"13","author":"R Torabi","year":"2012","journal-title":"J Reprod Infertil"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10815-019-01403-2","article-title":"The interaction effect of angiogenesis and endothelial dysfunction-related gene variants increases the susceptibility of recurrent pregnancy loss","volume":"36","author":"E A Trifonova","year":"2019","journal-title":"J Assist Reprod Genet"},{"issue":"03","key":"ref66","first-page":"116","article-title":"Thrombophilia and unexplained pregnancy loss in Indian patients","volume":"21","author":"S Vora","year":"2008","journal-title":"Natl Med J India"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s100380050200","article-title":"The 4G\/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia","volume":"45","author":"N Yamada","year":"2000","journal-title":"J Hum Genet"},{"issue":"02","key":"ref68","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0897.2009.00770.x","article-title":"A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss","volume":"63","author":"G I Yenicesu","year":"2010","journal-title":"Am J Reprod Immunol"},{"issue":"03","key":"ref69","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijgo.2006.07.014","article-title":"Total and free tissue factor pathway inhibitor in pregnancy hypertension","volume":"95","author":"A M Abdel Gader","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"issue":"01","key":"ref70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00404-014-3601-1","article-title":"Evaluation of Lp-PLA2 mass, vitronectin and PAI-1 activity levels in patients with preeclampsia","volume":"292","author":"\u00d6 Balc\u0131 Ekmek\u00e7i","year":"2015","journal-title":"Arch Gynecol Obstet"},{"issue":"07","key":"ref71","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1471-0528.2002.01330.x","article-title":"Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia","volume":"109","author":"S Djurovic","year":"2002","journal-title":"BJOG"},{"issue":"03","key":"ref72","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4314\/ahs.v18i3.15","article-title":"Fibrinolytic proteins of normal pregnancy and pre-eclamptic patients in North West Nigeria","volume":"18","author":"O Oladosu-Olayiwola","year":"2018","journal-title":"Afr Health Sci"},{"issue":"06","key":"ref73","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/00016349709024580","article-title":"Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation","volume":"76","author":"R Schjetlein","year":"1997","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"03","key":"ref74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1155\/2009\/658943","article-title":"Emerging role of endothelial and inflammatory markers in preeclampsia","volume":"26","author":"M Swellam","year":"2009","journal-title":"Dis Markers"},{"issue":"05","key":"ref75","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/aogs.12366","article-title":"Angiogenic factors and uterine Doppler velocimetry in early- and late-onset preeclampsia","volume":"93","author":"C M Tobinaga","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"04","key":"ref76","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/19396368.2018.1456576","article-title":"Association between thrombophilia gene polymorphisms and recurrent pregnancy loss risk in the Iranian population","volume":"64","author":"R Bigdeli","year":"2018","journal-title":"Syst Biol Reprod Med"},{"issue":"05","key":"ref77","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0897.2006.00376.x","article-title":"Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage","volume":"55","author":"C B Coulam","year":"2006","journal-title":"Am J Reprod Immunol"},{"issue":"05","key":"ref78","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1600-0897.2008.00640.x","article-title":"Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis","volume":"60","author":"C B Coulam","year":"2008","journal-title":"Am J Reprod Immunol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.37358\/RC.19.11.7654","article-title":"The genetic profile of thrombophilia in reproductive disorders","volume":"70","author":"G C Cozaru","year":"2019","journal-title":"Revista De Chimie"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2478\/jomb-2013-0040","article-title":"The prevalence of PAI-1 4G\/5G polymorphism in women with fetal loss - first data for a Serbian population","volume":"33","author":"V Dordevic","year":"2014","journal-title":"J Med Biochem"},{"key":"ref81","first-page":"440","article-title":"Lack of association between I\/D ACE and-675 ID 4G \/ 5G PAI-1 polymorphisms and predicting risk of pregnancy loss (PROPALO) in Bosnian women","volume":"62","author":"M Emir","year":"2017","journal-title":"Proceedings of the International Conference on Medical and Biological Engineering"},{"issue":"02","key":"ref82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijgo.2009.06.017","article-title":"Plasminogen activator inhibitor-1 4G\/5G gene polymorphism in women with fetal loss","volume":"107","author":"K Ghosh","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"06","key":"ref83","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0897.2009.00744.x","article-title":"Are polymorphisms in the ACE and PAI-1 genes associated with recurrent spontaneous miscarriages?","volume":"62","author":"C Goodman","year":"2009","journal-title":"Am J Reprod Immunol"},{"issue":"01","key":"ref84","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsgi.2003.07.008","article-title":"Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine fetal death: a multicenter study","volume":"11","author":"L Hefler","year":"2004","journal-title":"J Soc Gynecol Investig"},{"issue":"02","key":"ref85","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/14767058.2014.998189","article-title":"The investigation of hereditary and acquired thrombophilia risk factors in the development of complications in pregnancy in Croatian women","volume":"29","author":"B Lenz","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"66","DOI":"10.26641\/2307-0404.2020.2.206363","article-title":"Gene polymorphism of blood coagulation factors and endothelial dysfunction in early and late preeclampsia","volume":"25","author":"T O Loskutova","year":"2020","journal-title":"Medical Perspectives-Medicni Perspektivi"},{"issue":"05","key":"ref87","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-0037-1613083","article-title":"Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review","volume":"87","author":"E R Morrison","year":"2002","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref88","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10815-013-0071-5","article-title":"The association between thrombophilic gene mutations and recurrent pregnancy loss","volume":"30","author":"A Poursadegh Zonouzi","year":"2013","journal-title":"J Assist Reprod Genet"},{"issue":"10","key":"ref89","first-page":"627","article-title":"Association of plasminogen activator inhibitor-1 and angiotensin converting enzyme polymorphisms with recurrent pregnancy loss in Iranian women","volume":"13","author":"F Shakarami","year":"2015","journal-title":"Iran J Reprod Med"},{"issue":"01","key":"ref90","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/aji.12099","article-title":"Recurrent pregnancy loss, plasminogen activator inhibitor-1 (-675) 4G\/5G polymorphism and antiphospholipid antibodies in Czech women","volume":"70","author":"I Subrt","year":"2013","journal-title":"Am J Reprod Immunol"},{"issue":"06","key":"ref91","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MBC.0b013e328304dffc","article-title":"Thrombophilic dimension of recurrent fetal loss in Indian patients","volume":"19","author":"S Vora","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"04","key":"ref92","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3906\/sag-1502-132","article-title":"Coexistence of preeclampsia and inherited thrombophilia in Turkish pregnant women","volume":"46","author":"M Polat","year":"2016","journal-title":"Turk J Med Sci"},{"issue":"05","key":"ref93","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1160\/TH03-08-0546","article-title":"Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk","volume":"91","author":"T Hoekstra","year":"2004","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref94","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642556","article-title":"Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states","volume":"59","author":"E K Kruithof","year":"1988","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref95","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.ATV.18.4.562","article-title":"PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants","volume":"18","author":"M Margaglione","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"03","key":"ref96","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/molehr\/gas056","article-title":"Association between the SERPINE1 (PAI-1) 4G\/5G insertion\/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis","volume":"19","author":"L Zhao","year":"2013","journal-title":"Mol Hum Reprod"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.12659\/MSM.892898","article-title":"Meta-analysis of the association between plasminogen activator inhibitor-1 4G\/5G polymorphism and recurrent pregnancy loss","volume":"21","author":"X Li","year":"2015","journal-title":"Med Sci Monit"},{"issue":"11","key":"ref98","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1177\/1933719117702013","article-title":"Plasminogen Activator Inhibitor-1 Polymorphism Confers a Genetic Contribution to the Risk of Recurrent Spontaneous Abortion: An Updated Meta-Analysis","volume":"24","author":"Z Huang","year":"2017","journal-title":"Reprod Sci"},{"issue":"04","key":"ref99","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/aji.12321","article-title":"Association between plasminogen activator inhibitor-1 gene polymorphisms and recurrent pregnancy loss: a systematic review and meta-analysis","volume":"73","author":"H Chen","year":"2015","journal-title":"Am J Reprod Immunol"},{"issue":"01","key":"ref100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1160\/TH12-08-0584","article-title":"Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss: a systematic review and meta-analysis","volume":"109","author":"M T Su","year":"2013","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1097\/AOG.0000000000002703","article-title":"ACOG Practice Bulletin No. 197: inherited thrombophilias in pregnancy","volume":"132","author":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2013Obstetrics","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"05","key":"ref103","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3349\/ymj.2016.57.5.1230","article-title":"The impact of inherited thrombophilia types and low molecular weight heparin treatment on pregnancy complications in women with previous adverse outcome","volume":"57","author":"N Aracic","year":"2016","journal-title":"Yonsei Med J"},{"issue":"01","key":"ref104","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V84.1.143.143","article-title":"Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and\/or intrauterine fetal growth retardation","volume":"84","author":"A Estell\u00e9s","year":"1994","journal-title":"Blood"},{"issue":"04","key":"ref105","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.placenta.2006.05.005","article-title":"Differential release of plasminogen activator inhibitors (PAIs) during dual perfusion of human placenta: implications in preeclampsia","volume":"28","author":"S Guller","year":"2007","journal-title":"Placenta"},{"key":"ref106","first-page":"S0002","article-title":"Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis","author":"M Cruz-Lemini","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"622473","DOI":"10.3389\/fcvm.2020.622473","article-title":"Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition","volume":"7","author":"M Sillen","year":"2020","journal-title":"Front Cardiovasc Med"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1742082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T19:31:34Z","timestamp":1700076694000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1742082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":105,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2022,7,26]]},"published-print":{"date-parts":[[2022,7]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1742082","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,12]]}}}